Trustbridge Partners Co-Leads $30M Series B Round In Veritas Genetics

This Data Is Locked!

This area is available only to Subscribers.

Trustbridge Partners and Jiangsu Simcere Pharmaceutical, one of China’s largest drug companies, have led a US$30 million series B funding round in Veritas Genetics, a... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?